Dirk Holler

Dirk Holler is the General Manager for Germany and Austria at Advanced Accelerator Applications (AAA), a subsidiary of Novartis. He has held this position since December 2018, overseeing operations and strategic initiatives in these key markets. Holler has an extensive background in the pharmaceutical industry, with previous roles including Business Franchise Head for Rare Diseases and Head of Market Access at Novartis Pharma GmbH, as well as various positions at AstraZeneca, where he focused on market access and pricing strategies.13

Educational Background

Holler holds a degree in Health Economics from the University of Hanover and has also studied Pharmacy at both the University of Mainz and the University of Hanover.1

Professional Experience

• General Manager, Advanced Accelerator Applications (Novartis) (Dec 2018 - Present)
• Business Franchise Head, Rare Disease, Novartis Pharma GmbH (Jul 2014 - Feb 2017)
• Head Market Access, Novartis Oncology (Apr 2012 - Jun 2014)
• Director Market Access, AstraZeneca (Sep 2009 - Mar 2012)
• Global Director Pricing & Market Access, AstraZeneca (Feb 2007 - Aug 2009)
• Other roles at AstraZeneca and Schwarz Pharma focusing on health economics and market access.1

Skills and Languages

Holler is proficient in both German and English, which complements his role in managing diverse teams and engaging with stakeholders across Europe.1

His leadership at AAA is significant as the company specializes in developing radiopharmaceuticals for nuclear medicine, particularly in oncology, which aligns with Novartis's broader strategy to enhance its oncology portfolio through innovative therapies like Lutathera.24